首页> 外文期刊>BioMed research international >Effects of Crude Extracts from Medicinal HerbsRhazya strictaandZingiber officinaleon Growth and Proliferation of Human Brain Cancer Cell LineIn Vitro
【24h】

Effects of Crude Extracts from Medicinal HerbsRhazya strictaandZingiber officinaleon Growth and Proliferation of Human Brain Cancer Cell LineIn Vitro

机译:药材粗提物和生姜中药材粗提物对人脑癌细胞株体外生长和增殖的影响

获取原文
           

摘要

Hitherto, limited clinical impact has been achieved in the treatment of glioblastoma (GBMs). Although phytochemicals found in medicinal herbs can provide mankind with new therapeutic remedies, single agent intervention has failed to bring the expected outcome in clinical trials. Therefore, combinations of several agents at once are gaining increasing attractiveness. In the present study, we investigated the effects of crude alkaloid (CAERS) and flavonoid (CFEZO) extracts prepared from medicinal herbs,Rhazya strictaandZingiber officinale, respectively, on the growth of human GBM cell line, U251.R. strictaandZ. officinaleare traditionally used in folkloric medicine and have antioxidant, anticarcinogenic, and free radical scavenging properties. Combination of CAERS and CFEZO treatments synergistically suppressed proliferation and colony formation and effectively induced morphological and biochemical features of apoptosis in U251 cells. Apoptosis induction was mediated by release of mitochondrial cytochromec, increased Bax : Bcl-2 ratio, enhanced activities of caspase-3 and -9, and PARP-1 cleavage. CAERS and CFEZO treatments decreased expression levels of nuclear NF-κBp65, survivin, XIAP, and cyclin D1 and increased expression level of p53, p21, and Noxa. These results suggest that combination of CAERS and CFEZO provides a useful foundation for studying and developing novel chemotherapeutic agents for the treatment of GBM.
机译:迄今为止,在胶质母细胞瘤(GBM)的治疗中已经取得了有限的临床影响。尽管在草药中发现的植物化学物质可以为人类提供新的治疗方法,但是单药干预未能在临床试验中带来预期的结果。因此,几种试剂的组合一次获得越来越大的吸引力。在本研究中,我们研究了分别从药材严格生根和生姜提取的粗生物碱(CAERS)和类黄酮(CFEZO)提取物对人GBM细胞系U251.R的生长的影响。严格药用传统上用于民俗医学,并具有抗氧化剂,抗癌性和清除自由基的特性。 CAERS和CFEZO处理的组合可协同抑制U251细胞的增殖和集落形成,并有效诱导细胞凋亡的形态学和生化特征。凋亡的诱导是通过线粒体细胞色素的释放,Bax:Bcl-2比的增加,caspase-3和-9活性的增强以及PARP-1的切割介导的。 CAERS和CFEZO处理可降低核NF-κBp65,survivin,XIAP和cyclin D1的表达水平,并提高p53,p21和Noxa的表达水平。这些结果表明,CAERS和CFEZO的组合为研究和开发用于治疗GBM的新型化学治疗剂提供了有用的基础。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号